Nalaganje...
The Prevalence of BRAF Mutations in Patients with Glioma: A Systematic Review
BACKGROUND: The V600mutation in the v-raf murine sarcoma oncogene homologue B1 (BRAF) enzyme, is a potential clinically actionable target in gliomas. BRAF inhibitors are in wide clinical use for other tumour types, particularly melanoma. The prevalence of this mutation across all gliomas is not full...
Shranjeno v:
| izdano v: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789687/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz167.056 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|